Department of Neurology and the F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, 02115, USA.
Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Psychopharmacology (Berl). 2018 May;235(5):1371-1387. doi: 10.1007/s00213-018-4848-1. Epub 2018 Feb 22.
GLT-1 is the major glutamate transporter in the brain and is expressed predominantly in astrocytes but is also present in excitatory axon terminals. To understand the functional significance of GLT-1 expressed in neurons, we generated a conditional GLT-1 knockout mouse and inactivated GLT-1 in neurons using Cre-recombinase expressed under the synapsin 1 promoter, (synGLT-1 KO).
Abnormalities of glutamate homeostasis have been shown to affect hippocampal-related behaviors including learning and memory as well as responses to drugs of abuse. Here, we asked whether deletion of GLT-1 specifically from neurons would affect behaviors that assessed locomotor activity, cognitive function, sensorimotor gating, social interaction, as well as amphetamine-stimulated locomotor activity.
METHODS/RESULTS: We found that the neuronal GLT-1 KO mice performed similarly to littermate controls in the behavioral tests we studied. Although performance in open field testing was normal, the acute locomotor response to amphetamine was significantly blunted in the synGLT-1 KO (40% of control). We found no change in amphetamine-stimulated extracellular dopamine in the medial shell of the nucleus accumbens, no change in electrically stimulated or amphetamine-induced dopamine release, and no change in dopamine tissue content.
These results support the view that GLT-1 expression in neurons is required for amphetamine-induced behavioral activation, and suggest that this phenotype is not produced through a change in dopamine uptake or release. Although GLT-1 is highly expressed in neurons in the CA3 region of the hippocampus, the tests used in this study were not able to detect a behavioral phenotype referable to hippocampal dysfunction.
GLT-1 是大脑中主要的谷氨酸转运体,主要表达于星形胶质细胞,但也存在于兴奋性轴突末梢。为了了解在神经元中表达的 GLT-1 的功能意义,我们生成了条件性 GLT-1 敲除小鼠,并使用突触素 1 启动子表达的 Cre 重组酶使神经元中的 GLT-1 失活(synGLT-1 KO)。
谷氨酸稳态的异常已被证明会影响与海马相关的行为,包括学习和记忆以及对滥用药物的反应。在这里,我们询问是否从神经元中特异性删除 GLT-1 会影响评估运动活动、认知功能、感觉运动门控、社交互动以及安非他命刺激的运动活动的行为。
方法/结果:我们发现神经元 GLT-1 KO 小鼠在我们研究的行为测试中与同窝对照表现相似。尽管在开阔场测试中的表现正常,但 synGLT-1 KO 中的安非他命急性运动反应明显减弱(对照的 40%)。我们没有发现中脑伏隔核内侧壳中安非他命刺激的细胞外多巴胺有变化,电刺激或安非他命诱导的多巴胺释放没有变化,多巴胺组织含量也没有变化。
这些结果支持 GLT-1 在神经元中的表达对于安非他命诱导的行为激活是必需的观点,并表明这种表型不是通过多巴胺摄取或释放的改变产生的。尽管 GLT-1 在海马体 CA3 区的神经元中高度表达,但在本研究中使用的测试未能检测到与海马体功能障碍有关的行为表型。